Learn more Zometa® (zoledronic acid) & its approved indications, courtesy of Novartis Oncology.

3.00 Rating by CuteStat

zometa.com is 2 decades 5 years old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, zometa.com is SAFE to browse.

PageSpeed Score
80
Siteadvisor Rating
No Risk Issues

Traffic Report

Daily Unique Visitors: Not Applicable
Daily Pageviews: Not Applicable

Estimated Valuation

Income Per Day: $ 0.15
Estimated Worth: $ 8.95

Search Engine Indexes

Google Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: No Risk Issues
WOT Trustworthiness: Not Applicable
WOT Child Safety: Not Applicable

Website Ranks & Scores

Alexa Rank: Not Applicable
Domain Authority: Not Applicable

Web Server Information

Hosted IP Address:

217.114.92.50

Hosted Country:

Sweden SE

Location Latitude:

59.3247

Location Longitude:

18.056

Page Resources Breakdown

Homepage Links Analysis

Website Inpage Analysis

H1 Headings: 1 H2 Headings: 5
H3 Headings: Not Applicable H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: 1 Total Images: 2
Google Adsense: Not Applicable Google Analytics: Not Applicable

Websites Hosted on Same IP (i.e. 217.114.92.50)

Temporary Page

- setyoursights.com
5,768,785 $ 240.00

AFINITOR® (everolimus) | Official Site from Novartis

- afinitor.com

The official website for AFINITOR® (everolimus) tablets. Find information about AFINITOR®, the conditions it treats, and Important Safety Information.

2,946,082 $ 480.00

SANDOSTATIN® LAR Depot (octreotide acetate) for Acromegaly and Carcino

- sandostatin.com

Learn about SANDOSTATIN® LAR Depot (octreotide acetate) for injectable suspension for acromegaly and carcinoid syndrome. See Important Safety Information.

Not Applicable $ 8.95

Home | EXJADE® (deferasirox) FILM-COATED TABLETS

- exjade.com

Learn about EXJADE®, an iron chelation therapy for the management of chronic iron overload due to blood transfusions. See safety & product information.

9,205,258 $ 240.00

FEMARA® (letrozole) | 1L Treatment for HR+ Metastatic Breast Cancer

- femara.com

Discover FEMARA® (letrozole), an approved treatment from Novartis Oncology for HR+ breast cancer in postmenopausal women. Learn about FEMARA® side effects & see recommended FEMARA® dosage information.

Not Applicable $ 8.95

HTTP Header Analysis

HTTP/1.1 200 OK
Date: Sun, 18 Jun 2017 10:02:16 GMT
Content-Type: text/html; charset=utf-8
Connection: close
X-Drupal-Cache: HIT
X-Content-Type-Options: nosniff
Content-Language: en
X-Frame-Options: SAMEORIGIN
X-UA-Compatible: IE=edge,chrome=1
Link: <https://www.novartisoncology.com/news/product-portfolio/zometa>; rel="canonical",<https://www.novartisoncology.com/node/11811>; rel="shortlink"
Cache-Control: public, max-age=21600
Last-Modified: Sun, 18 Jun 2017 10:00:55 GMT
Expires: Sun, 18 Jun 2017 16:02:16 GMT
Vary: Accept-Encoding
X-Request-ID: a4ad3c38-de85-4b4c-b8bb-5dfdba74823c
X-AH-Environment: prod
CF-Cache-Status: EXPIRED
Server: cloudflare-nginx
CF-RAY: 370d69784dbf5e70-TPA
Content-Encoding: gzip

Domain Information

Domain Registrar: MarkMonitor, Inc.
Registration Date: Nov 18, 1998, 12:00 AM 2 decades 5 years 5 months ago
Last Modified: Oct 16, 2015, 12:00 AM 8 years 6 months 4 weeks ago
Expiration Date: Nov 17, 2017, 12:00 AM 6 years 5 months 4 weeks ago
Domain Status:
clientDeleteProhibited
clientTransferProhibited
clientUpdateProhibited

Domain Nameserver Information

Host IP Address Country
mia03.digex.com 216.255.129.246 United States of America United States of America
dns1.novartis.com 160.62.4.7 Switzerland Switzerland
dns2.novartis.com 160.62.7.59 Switzerland Switzerland

DNS Record Analysis

Host Type TTL Extra
zometa.com A 86393 IP: 217.114.92.50
zometa.com NS 86399 Target: dns1.novartis.com
zometa.com NS 86399 Target: dns2.novartis.com
zometa.com NS 86399 Target: mia03-1.digex.com
zometa.com SOA 86399 MNAME: dns1.novartis.com
RNAME: hostmaster.novartis.com
Serial: 2016122006
Refresh: 28800
Retry: 7200
Expire: 604800
Minimum TTL: 3600

Full WHOIS Lookup

Domain Name: zometa.com
Registry Domain ID: 2454532_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.markmonitor.com
Registrar URL: http://www.markmonitor.com
Updated Date: 2017-06-18T00:10:01-0700
Creation Date: 1998-11-18T00:00:00-0800
Registrar Registration Expiration Date: 2017-11-16T21:00:00-0800
Registrar: MarkMonitor, Inc.
Registrar IANA ID: 292
Registrar Abuse Contact Email: abusecomplaints@markmonitor.com
Registrar Abuse Contact Phone: +1.2083895740
Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited)
Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited)
Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited)
Registry Registrant ID:
Registrant Name: Domain Admin
Registrant Organization: Novartis AG
Registrant Street: P.O. Box CH-4002,
Registrant City: Basel
Registrant State/Province:
Registrant Postal Code: 4002
Registrant Country: CH
Registrant Phone: +1.2083895740
Registrant Phone Ext:
Registrant Fax: +1.2083895799
Registrant Fax Ext:
Registrant Email: novartis.domains@markmonitor.com
Registry Admin ID:
Admin Name: Domain Admin
Admin Organization: MarkMonitor, Inc.
Admin Street: 3540 East Longwing Lane, Suite 300
Admin City: Meridian
Admin State/Province: ID
Admin Postal Code: 83646
Admin Country: US
Admin Phone: +1.2083895740
Admin Phone Ext:
Admin Fax: +1.2083895799
Admin Fax Ext:
Admin Email: novartis.domains@markmonitor.com
Registry Tech ID:
Tech Name: Domain Admin
Tech Organization: MarkMonitor, Inc.
Tech Street: 3540 East Longwing Lane, Suite 300
Tech City: Meridian
Tech State/Province: ID
Tech Postal Code: 83646
Tech Country: US
Tech Phone: +1.2083895740
Tech Phone Ext:
Tech Fax: +1.2083895799
Tech Fax Ext:
Tech Email: novartis.domains@markmonitor.com
Name Server: mia03.digex.com
Name Server: dns2.novartis.com
Name Server: dns1.novartis.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2017-06-18T03:02:21-0700